Charles Schoch Candel Therapeutics, Inc. (CADL) insider trading activity

CADL Quotes by TradingView

Charles Schoch is Chief Financial Officer of Candel Therapeutics, Inc.. Currently has a direct ownership of 43,391 shares of CADL, which is worth approximately $297,228. The most recent transaction as insider was on Jun 25, 2025, when has been sold 5,353 shares (Common Stock) at a price of $4.67 per share, resulting in proceeds of $24,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.4K
14.07% 3M change
30.6% 12M change
Total Value Held $297,228

Charles Schoch Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 25 2025
BUY
Grant, award, or other acquisition
$24,998 $4.67 p/Share
5,353 Added 10.98%
43,391 Common Stock
Mar 17 2025
SELL
Open market or private sale
$44,150 $8.83 p/Share
5,000 Reduced 11.62%
38,038 Common Stock
Jan 15 2025
SELL
Open market or private sale
$68,669 $7.22 p/Share
9,511 Reduced 18.1%
43,038 Common Stock
Jan 08 2025
SELL
Open market or private sale
$81,961 $8.22 p/Share
9,971 Reduced 15.95%
52,549 Common Stock
Jul 17 2024
SELL
Open market or private sale
$63,949 $6.47 p/Share
9,884 Reduced 13.65%
62,520 Common Stock
Jul 11 2024
SELL
Open market or private sale
$53,115 $5.97 p/Share
8,897 Reduced 10.94%
72,404 Common Stock
CS

Charles Schoch

Chief Financial Officer
Needham, MA

Track Institutional and Insider Activities on CADL

Follow Candel Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CADL shares.

Notify only if

Insider Trading

Get notified when an Candel Therapeutics, Inc. insider buys or sells CADL shares.

Notify only if

News

Receive news related to Candel Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CADL